John J. Kirby is CHIEF FINANCIAL OFFICER of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 316,893 shares of IDRA, which is worth approximately $953,847. The most recent transaction as insider was on Jan 06, 2023, when has been sold 119,957 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $85,169. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 317K
0% 3M change
0% 12M change
Total Value Held $953,847

John J. Kirby Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2023
SELL
Payment of exercise price or tax liability
$85,169 $0.71 p/Share
119,957 Reduced 27.46%
316,893 Common Stock
Jan 06 2023
BUY
Grant, award, or other acquisition
-
399,218 Added 47.75%
436,850 Common Stock
Dec 17 2021
BUY
Open market or private purchase
$6,200 $0.62 p/Share
10,000 Added 20.99%
37,632 Common Stock
Mar 25 2021
SELL
Open market or private sale
$8,875 $1.42 p/Share
6,250 Reduced 18.45%
27,632 Common Stock
Jan 12 2021
SELL
Open market or private sale
$7,144 $4.22 p/Share
1,693 Reduced 4.76%
33,882 Common Stock
Jan 05 2021
SELL
Open market or private sale
$3,362 $3.9 p/Share
862 Reduced 2.37%
35,575 Common Stock

Also insider at

VRCA
Verrica Pharmaceuticals Inc. Healthcare
JJK

John J. Kirby

CHIEF FINANCIAL OFFICER
Exton, PA

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Track Activities on IDRA